Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008;7:771–782.
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29:1912–1919.
PR_b-targeted delivery of tumor necrosis factor-alpha by polymersomes for the treatment of prostate cancer. Soft Matter. 2009;5:2011–2019.
The studies of N-octyl-N-arginine-chitosan coated liposome as an oral delivery system of cyclosporine A. J. Pharm. Pharmacol. 2015;67:1363–1370.